All EBF1-PDGFR-ß and CRLF2-IGH rearrangement positive cases as well as five of six ALL harboring EPOR-IGH fusions were found in the MRD very high-risk group. This evidence concerns the gene EBF1 and acute lymphoblastic leukemia.